{
    "organizations": [],
    "uuid": "7120201857cb7e99e83e5891420caf77bfe7ce4b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-mylan-to-bring-biosimilar-of-botox/brief-mylan-to-bring-biosimilar-of-botox-to-market-through-collaboration-with-revance-therapeutics-idUSFWN1QI1JE",
    "ord_in_thread": 0,
    "title": "BRIEF-Mylan To Bring Biosimilar Of Botox To Market Through Collaboration With Revance Therapeutics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 28, 2018 / 9:16 PM / Updated 8 minutes ago BRIEF-Mylan To Bring Biosimilar Of Botox To Market Through Collaboration With Revance Therapeutics Reuters Staff 1 Min Read Feb 28 (Reuters) - Mylan Nv: * MYLAN TO BRING A BIOSIMILAR OF BOTOX TO THE MARKET THROUGH A COLLABORATION AND LICENSE AGREEMENT WITH REVANCE THERAPEUTICS * MYLAN NV - ‍COLLABORATION AND LICENSE DEAL FOR DEVELOPMENT AND COMMERCIALIZATION OF A PROPOSED BIOSIMILAR TO BOTOX​ * MYLAN NV - ‍COLLABORATION INCLUDES AN UPFRONT PAYMENT OF $25 MILLION TO REVANCE​ * MYLAN TO BRING A BIOSIMILAR OF BOTOX TO THE MARKET THROUGH A COLLABORATION AND LICENSE AGREEMENT WITH REVANCE THERAPEUTICS Source text for Eikon: Further company coverage:",
    "published": "2018-02-28T23:16:00.000+02:00",
    "crawled": "2018-02-28T23:30:57.038+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "bring",
        "biosimilar",
        "botox",
        "market",
        "collaboration",
        "revance",
        "therapeutic",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "mylan",
        "nv",
        "mylan",
        "bring",
        "biosimilar",
        "botox",
        "market",
        "collaboration",
        "license",
        "agreement",
        "revance",
        "therapeutic",
        "mylan",
        "nv",
        "license",
        "deal",
        "development",
        "commercialization",
        "proposed",
        "biosimilar",
        "mylan",
        "nv",
        "includes",
        "upfront",
        "payment",
        "million",
        "mylan",
        "bring",
        "biosimilar",
        "botox",
        "market",
        "collaboration",
        "license",
        "agreement",
        "revance",
        "therapeutic",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}